HIV treatment, antiretroviral therapy, and AIDS medications
The US Food and Drug Administration has approved fostemsavir (Rukobia, ViiV Healthcare), a first-in-class attachment inhibitor for the treatment of HIV-1 infection in adults. Fostemsavir is indicated for use in…
Continue Reading
FDA OKs First-in-Class HIV Therapy for Patients With Few Options
The US Food and Drug Administration (FDA) has approved the first dispersible tablet formulation of dolutegravir (Tivicay PD, ViiV Healthcare) to treat HIV-1 infection in children at least 4 weeks old and…
Continue Reading
FDA OKs First Dispersible Form of Dolutegravir for Infants
First recognized in 1988, World AIDS Day falls on December 1 each year. World AIDS Day is dedicated to spreading awareness of the AIDS pandemic spread by the spread of…
